"significantly to the continued existence of parasites in the community. products which, although still marketed as patent medicines, will soon come into the public domain. All these advantages, however, are of value only if the short treatment equals or surpasses the long treatment in effectiveness. Studies concerning tuberculosis are significant in this respect. Most of them agree that the rate of failure and relapse is 5-10% using the conventional treatments, whereas it is 0-2% for the short treatments. The rate of discontinued treatment is even more significant. According to an evaluation carried out in Peru, 41% of patients discontinued treatment (12 months)."